$4.19
-0.04-0.95%
Last update: Oct 30, 4:35 PM
Artiva Biotherapeutics Inc (ARTV) Stock Price, Quote, News & History
ARTVNASDAQ
Major M&A deals this week include: Blue Matter buys Cognite, RadNet acquires ONRAD, Oak Hill Capital buys Wyyerd.
You can purchase shares of Artiva Biotherapeutics (NASDAQ:ARTV) through any online brokerage.
Other companies in Artiva Biotherapeutics’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Regeneron Pharmaceuticals Inc (NASDAQ:REGN).
Artiva Biotherapeutics has a consensus price target of $23.43.
The stock price for Artiva Biotherapeutics (NASDAQ: ARTV) is $4.2133 last updated October 30, 2026 at 4:35 PM EDT.
There are no upcoming dividends for Artiva Biotherapeutics.
Artiva Biotherapeutics does not have any upcoming earnings scheduled.
There is no upcoming split for Artiva Biotherapeutics.
Artiva Biotherapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Artiva Biotherapeutics Inc is a biopharmaceutical company. The company is engaged in advancing a pipeline of off-the-shelf, allogeneic NK cell therapies for the treatment of hematologic malignancies or solid tumors. The pipeline program of the...
